Heck Capital Advisors, LLC Adma Biologics, Inc. Transaction History
Heck Capital Advisors, LLC
- $1.47 Trillion
- Q4 2024
A detailed history of Heck Capital Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 13,123 shares of ADMA stock, worth $216,135. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,123Holding current value
$216,135% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
314Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$307 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$298 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$214 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$208 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$142 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.23B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...